S'pore drug development gets another shot in the arm
One goal for EDDC will be to create projects that are attractive to multinational pharmaceutical companies
Add BT as a preferred source
Singapore
A*STAR officially opened the new Experimental Drug Development Centre (EDDC) on Wednesday to take more made-in-Singapore drugs from early-stage drug discovery to clinical trials and commercialisation.
Towards this end, the statutory board also launched the Target Translation Consortium (TTC), which coordinates drug discovery efforts in academia, healthcare institutions and government agencies, and consolidated three existing A*Star grants into the Singapore Therapeutics Development Review (STDR).
TRENDING NOW
Eligible Singaporeans to receive up to S$850 in GSTV cash, up to S$450 in MediSave top-ups in August
Supermarket and minimart chain Hao Mart faces fifth High Court lawsuit
DBS, OCBC, UOB push STI to new highs as institutions pile in ahead of earnings
With AI, it’s not about coding better; workers need to think better: Koh Boon Hwee
